Severe acute respiratory syndrome coronavirus 2, the causative agent of coronavirus disease 2019, is capable of causing severe respiratory distress syndrome, cytokine release syndrome, multi-organ failure, and has been associated with many neurologic complications. No treatment has proven to be very effective. Therapeutic plasma exchange has been proposed and used. To date, randomized controlled trials have not been completed to show therapeutic benefit.

Commentary on Therapeutic Plasma Exchange to Treat COVID-19

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info